Furthermore, treatments with isoproterenol decreased the expression of Bax and increased expression of Bcl2 (Figures 3G,H), suggesting that TRPM7 expression and function are modulated via isoproterenol, which is essential for the neurotoxin-induced survival of neuroblastoma cells. The gene discussed is BAX; the disease is neuroblastoma.